Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US.
| Image |  |
|---|---|
| Description | scientific article published on 30 January 2018 |
| Author/s |
author: Canadian Respiratory Research Network Mohsen Sadatsafavi |
| Publication date | January 30, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |